What is the toxic dose of paracetamol (acetaminophen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Toxic Dose of Paracetamol

In acute single ingestions, paracetamol becomes potentially hepatotoxic at doses of ≥10 g or ≥200 mg/kg (whichever is less) in adults and children ≥6 years, and ≥200 mg/kg in children <6 years. 1, 2, 3

Acute Single Ingestion Thresholds

The toxic dose varies by age and clinical context:

Adults and Children ≥6 Years

  • Emergency department referral required: ≥10 g or ≥200 mg/kg (whichever is less) 2, 3
  • Hepatotoxicity unlikely: <125 mg/kg 4
  • Maximum safe daily therapeutic dose: 4000 mg (4 g) 5

Children <6 Years

  • Emergency department referral required: ≥200 mg/kg 2, 3
  • Home observation acceptable: <200 mg/kg 2
  • Children generally tolerate higher doses per kilogram without liver damage compared to adults 4

Repeated Supratherapeutic Ingestion (RSTI)

RSTI represents a distinct and potentially more dangerous pattern, with worse prognosis than acute overdose 1. Emergency department referral is warranted if:

Children <6 Years

  • ≥200 mg/kg over single 24-hour period, OR
  • ≥150 mg/kg per 24-hour period for preceding 48 hours, OR
  • ≥100 mg/kg per 24-hour period for ≥72 hours 2

Adults and Children ≥6 Years

  • ≥10 g or ≥200 mg/kg (whichever is less) over single 24-hour period, OR
  • ≥6 g or ≥150 mg/kg (whichever is less) per 24-hour period for preceding 48 hours or longer 1, 2, 3

High-Risk Patients

For patients with increased susceptibility (chronic alcohol use, isoniazid therapy, prolonged fasting, enzyme-inducing drugs), the threshold should be lowered to:

  • ≥4 g or ≥100 mg/kg (whichever is less) per day 1, 2, 6

Critical Clinical Considerations

Massive Overdose

Ingestions of ≥30 g or ≥500 mg/kg require increased acetylcysteine dosing due to higher risk of severe hepatotoxicity 7. Paracetamol concentrations more than double the nomogram line indicate massive overdose requiring modified treatment 7.

Modified-Release Formulations

All potentially toxic modified-release ingestions (≥10 g or ≥200 mg/kg, whichever is less) require full acetylcysteine treatment 7. These formulations demonstrate:

  • Persistently elevated paracetamol concentrations
  • Double peaks (sometimes >24 hours post-ingestion)
  • Higher hepatotoxicity rates (18%) despite early treatment
  • 10% of patients cross the nomogram line after initially non-toxic levels 8

Timing and Risk Stratification

The Rumack-Matthew nomogram is used for risk stratification only when:

  • Single acute ingestion with known time
  • Immediate-release formulation
  • Presentation within 24 hours
  • Serum level drawn 4-24 hours post-ingestion 1

Common pitfall: The nomogram cannot be used for repeated supratherapeutic ingestions, unknown ingestion times, delayed presentations >24 hours, or extended-release preparations 1.

Hepatotoxicity Outcomes

Without treatment, severe liver damage (AST >1000 IU/L) occurs in at least 50% of patients with levels above the treatment line 4. However, mortality from paracetamol overdose is approximately 0.4% with appropriate treatment 4. Treatment efficacy is time-dependent:

  • NAC within 8 hours: minimal hepatotoxicity (2.9%) 1
  • NAC 8-10 hours: 6.1% severe hepatotoxicity 1
  • NAC >10 hours: 26.4% severe hepatotoxicity 1

FDA Warning Thresholds

The FDA label explicitly warns that severe liver damage may occur if an adult takes >6 doses in 24 hours or >4000 mg total daily 5. This represents the maximum therapeutic threshold, not the toxic threshold.

Key distinction: Therapeutic misadventure (exceeding 4 g/day) differs from acute toxic ingestion (≥10 g or ≥200 mg/kg). Both require evaluation but follow different risk assessment pathways 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.